Topical Carboxytherapy Paste Following Microneedling

ConditionSkin
Trial statusNot yet recruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorVanderbilt University Medical Center

About this trial

Topical carboxytherapy refers to a gel paste that carries non-gaseous carbon dioxide (CO2). It is applied similarly to a face mask. Topical carboxytherapy has been shown to increase local blood flow and can help with wound healing. Few studies have researched how topical carboxytherapy can be used to aid skin rejuvenation in the field of facial plastic and reconstructive surgery. The goal of this study is to evaluate how topical carboxytherapy can improve skin healing after microneedling. Common temporary side effects of microneedling include redness and swelling, sometimes lasting up to a week post-procedure. If topical carboxytherapy reduces downtime related to side effects of microneedling, the investigators may offer this treatment to more microneedling patients in the future.

Eligibility criteria

Qualifiers

None

Disqualifiers

Age under 18

Pregnant patients

Patients with other known medical conditions which affect facial cosmesis

Patients who have recently undergone surgery to the facial region or minimally invasive facial procedures within the past month

Trial design

Treatments tested in this trial

  • CO2 gel mask

Treatment groups

20 Participants
are divided into 1 treatment group

Locations

This trial has no locations